How much is XBiotech stock worth?
One share of XBIT stock can currently be purchased for approximately $10.11. How much money does XBiotech make? XBiotech has a market capitalization of $307.33 million and generates $40 thousand in revenue each year. The biopharmaceutical company earns $-11.22 million in net income (profit) each year or ($0.43) on an earnings per share basis.
Where can I buy shares of Xbit?
Shares of XBIT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is XBiotech’s xb2001 a good investment?
XBiotech’s novel anti-cancer agent, XB2001, is being assessed in combin Performance at XBiotech Inc. ( NASDAQ:XBIT ) has been reasonably good and CEO John Simard has done a decent job of...
How much does xfxbiotech (xfxb) make a year?
XBiotech has a market capitalization of $307.33 million and generates $40 thousand in revenue each year. The biopharmaceutical company earns $-11.22 million in net income (profit) each year or ($0.43) on an earnings per share basis.
How has XBiotech's stock price performed in 2022?
XBiotech's stock was trading at $11.13 at the beginning of the year. Since then, XBIT shares have decreased by 49.1% and is now trading at $5.67....
When is XBiotech's next earnings date?
XBiotech is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for XBiotech .
How often does XBiotech pay dividends? What is the dividend yield for XBiotech?
XBiotech declared a dividend on Tuesday, July 6th. Investors of record on Friday, July 16th will be paid a dividend of $2.50 per share on Friday, J...
Who are XBiotech's key executives?
XBiotech's management team includes the following people: Mr. John Simard , Founder, Pres, CEO & Chairman (Age 60, Pay $3.42M) Ms. Queena Han CP...
What is John Simard's approval rating as XBiotech's CEO?
20 employees have rated XBiotech CEO John Simard on Glassdoor.com . John Simard has an approval rating of 58% among XBiotech's employees. This put...
Who are some of XBiotech's key competitors?
Some companies that are related to XBiotech include Evolus (EOLS) , MorphoSys (MOR) , Catalyst Pharmaceuticals (CPRX) , Pharvaris (PHVS) , Mir...
What other stocks do shareholders of XBiotech own?
Based on aggregate information from My MarketBeat watchlists, some companies that other XBiotech investors own include Micron Technology (MU) , G...
When did XBiotech IPO?
(XBIT) raised $76 million in an initial public offering (IPO) on Wednesday, April 15th 2015. The company issued 4,000,000 shares at $18.00-$20.00 p...
What is XBiotech's stock symbol?
XBiotech trades on the NASDAQ under the ticker symbol "XBIT."
About XBiotech
XBiotech (NASDAQ:XBIT) Frequently Asked Questions
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
